- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.05. | Stopping a 'moral obscenity': Senate Judiciary Committee expresses support for PBM reform | ||
| 14.05. | Novo to work with Septerna in hunt for oral obesity drugs | ||
| 14.05. | Bluebird extends deal deadline; Affimed files for insolvency | ||
| 14.05. | GSK to buy liver disease drug for $1.2B | ||
| 13.05. | Women's health faces growing headwinds, despite jump in venture investment | ||
| 13.05. | 5 questions on Trump's plan to lower US drug prices | ||
| 13.05. | Galapagos backtracks on planned split | ||
| 13.05. | iTeos, GSK to shelve TIGIT drug after study setback | ||
| 13.05. | Andrew Witty steps down as UnitedHealth CEO | ||
| 12.05. | FDA follows EMA in limiting use of Valneva shot | ||
| 12.05. | Trump revives 'most favored nation' plan in effort to cut US drug prices | ||
| 12.05. | Abeona sells speedy drug review voucher for $155M | ||
| 12.05. | Innovating a healthier tomorrow: Entering a new era of medicine | ||
| 12.05. | [Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care | ||
| 09.05. | Eli Lilly extends Purdue alliance; EMA investigates Valneva shot | ||
| 08.05. | 4 more biotechs cut staff amid market tumult | ||
| 08.05. | Viatris' new form of old pain drug scores in large trials | ||
| 08.05. | Gilead, bracing for tariffs, joins peers in US drug production push | ||
| 08.05. | Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues. | ||
| 08.05. | Haya banks $65M to scour the 'dark genome' for new drugs | ||
| 07.05. | FDA set to meet this month on COVID vaccines | ||
| 07.05. | Novo cuts forecasts as compounded GLP-1s weigh on sales | ||
| 07.05. | Sarepta shares plummet as lower sales outlook adds to gloom over FDA's new biologics hire | ||
| 06.05. | Prasad's FDA appointment pressures cell and gene therapy stocks | ||
| 06.05. | Vinay Prasad, a physician and FDA critic, to lead agency center overseeing vaccines |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .